Abbott ABT Established Pharmaceuticals — Additions to Property and Equipment

Other segment segments

Similar metrics at other companies

ALife Sciences and Applied Markets — Capital Expenditures

$15M-6.3%

WSTProprietary Products — Payments to Acquire Property, Plant, and Equipment

$59.33M+8.9%

TSNOperating Segments — PP&E Additions

$235M+50.2%

PSXChemicals — Capital Expenditures and Investments

$0—

ALife Sciencesand Applied Markets — CapEx

$19.25M+20.3%

DECKOperating Segments — PP&E Additions

$2.18M-53.9%

Questions, answered.

What is Abbott's established pharmaceuticals — additions to property and equipment?

Abbott (ABT) reported established pharmaceuticals — additions to property and equipment of $20M in Q1 2026.

How has Abbott's established pharmaceuticals — additions to property and equipment changed year-over-year?

Abbott's established pharmaceuticals — additions to property and equipment decreased by 39.4% year-over-year, from $33M to $20M.

What is the long-term trend for Abbott's established pharmaceuticals — additions to property and equipment?

Over 4 years (2021 to 2025), Abbott's established pharmaceuticals — additions to property and equipment has grown at a 0.0% compound annual growth rate (CAGR), from $169M to $169M.

What does established pharmaceuticals — additions to property and equipment mean?

The amount of money invested in physical assets and infrastructure specifically for the Established Pharmaceuticals business segment.

How do you interpret established pharmaceuticals — additions to property and equipment?

An increase suggests management is investing in future production capacity or facility upgrades, while a decrease may indicate a focus on capital preservation or a shift toward asset-light operations.

How does established pharmaceuticals — additions to property and equipment compare across companies?

Comparable to 'Capital Expenditures' or 'Additions to Property, Plant, and Equipment' reported by other pharmaceutical companies for specific business units.